Global and United States Myotonic Dystrophy Drug Market 2018 - Research Report, Demand, Price, By Application, Region and Forecast to 2025

 Published Date : Aug-2018   |    Format :PDF |    Number of Pages : 129   |    Publisher : e-Market Research

Summary

This report studies the Myotonic Dystrophy Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Myotonic Dystrophy Drug market by product type and application/end industries.

The global Myotonic Dystrophy Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Myotonic Dystrophy Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Myotonic Dystrophy Drug in these regions, from 2013 to 2025 (forecast), covering
    United States
    North America
    Europe
    Asia-Pacific
    South America
    Middle East and Africa

The major players in global and United States market, including
    BioMarin Pharmaceutical Inc.
    F. Hoffmann-La Roche Ltd.
    Genzyme Corporation
    Isis Pharmaceuticals, Inc.
    Marina Biotech, Inc.
    Valentia Biopharma S.L.
On the basis of product, the market is primarily split into
    ISIS-DMPKRx
    PRO-135
    SRT-152
    VAL-0411
    Others
On the basis on the end users/application, this report covers
    Hospital
    Clinic
    Home Use
    Others

2018-2025 Myotonic Dystrophy Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

2 Myotonic Dystrophy Drug Market Overview
    2.1 Myotonic Dystrophy Drug Product Overview
    2.2 Myotonic Dystrophy Drug Market Segment by Type
        2.2.1 ISIS-DMPKRx
        2.2.2 PRO-135
        2.2.3 SRT-152
        2.2.4 VAL-0411
        2.2.5 Others
    2.3 Global Myotonic Dystrophy Drug Product Segment by Type
        2.3.1 Global Myotonic Dystrophy Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
        2.3.2 Global Myotonic Dystrophy Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
        2.3.3 Global Myotonic Dystrophy Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
        2.3.4 Global Myotonic Dystrophy Drug Price (USD/Pcs) by Type (2013-2018)
    2.4 United States Myotonic Dystrophy Drug Product Segment by Type
        2.4.1 United States Myotonic Dystrophy Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
        2.4.2 United States Myotonic Dystrophy Drug Sales (K Pcs) and Market Share by Type (2013-2018)
        2.4.3 United States Myotonic Dystrophy Drug Revenue (Million USD) and Market Share by Type (2013-2018)
        2.4.4 United States Myotonic Dystrophy Drug Price (USD/Pcs) by Type (2013-2018)

3 Myotonic Dystrophy Drug Application/End Users
    3.1 Myotonic Dystrophy Drug Segment by Application/End Users
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Home Use
        3.1.4 Others
    3.2 Global Myotonic Dystrophy Drug Product Segment by Application
        3.2.1 Global Myotonic Dystrophy Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.2.2 Global Myotonic Dystrophy Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
    3.3 United States Myotonic Dystrophy Drug Product Segment by Application
        3.3.1 United States Myotonic Dystrophy Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.3.2 United States Myotonic Dystrophy Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 Myotonic Dystrophy Drug Market Status and Outlook by Regions
    4.1 Global Market Status and Outlook by Regions
        4.1.1 Global Myotonic Dystrophy Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
        4.1.2 North America
        4.1.3 Asia-Pacific
        4.1.4 Europe
        4.1.5 South America
        4.1.6 Middle East and Africa
        4.1.7 United States
    4.2 Global Myotonic Dystrophy Drug Sales and Revenue by Regions
        4.2.1 Global Myotonic Dystrophy Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
        4.2.2 Global Myotonic Dystrophy Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
        4.2.3 Global Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.4 North America Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.5 Europe Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.6 Asia-Pacific Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.7 South America Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
        4.2.8 Middle East and Africa Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.9 United States Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 Global Myotonic Dystrophy Drug Market Competition by Players/Manufacturers
    5.1 Global Myotonic Dystrophy Drug Sales (K Pcs) and Market Share by Players (2013-2018)
    5.2 Global Myotonic Dystrophy Drug Revenue (Million USD) and Share by Players (2013-2018)
    5.3 Global Myotonic Dystrophy Drug Average Price (USD/Pcs) by Players (2013-2018)
    5.4 Global Top Players Myotonic Dystrophy Drug Manufacturing Base Distribution, Sales Area, Product Types
    5.5 Myotonic Dystrophy Drug Market Competitive Situation and Trends
        5.5.1 Myotonic Dystrophy Drug Market Concentration Rate
        5.5.2 Global Myotonic Dystrophy Drug Market Share (%) of Top 3 and Top 5 Players
        5.5.3 Mergers & Acquisitions, Expansion

6 United States Myotonic Dystrophy Drug Market Competition by Players/Manufacturers
    6.1 United States Myotonic Dystrophy Drug Sales (K Pcs) and Market Share by Players (2013-2018)
    6.2 United States Myotonic Dystrophy Drug Revenue (Million USD) and Share by Players (2013-2018)
    6.3 United States Myotonic Dystrophy Drug Average Price (USD/Pcs) by Players (2013-2018)
    6.4 United States Myotonic Dystrophy Drug Market Share (%) of Top 3 and Top 5 Players


7 Myotonic Dystrophy Drug Players/Manufacturers Profiles and Sales Data
    7.1 BioMarin Pharmaceutical Inc.
        7.1.1 Company Basic Information, Manufacturing Base and Competitors
        7.1.2 Myotonic Dystrophy Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.1.4 Main Business/Business Overview
    7.2 F. Hoffmann-La Roche Ltd.
        7.2.1 Company Basic Information, Manufacturing Base and Competitors
        7.2.2 Myotonic Dystrophy Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.2.4 Main Business/Business Overview
    7.3 Genzyme Corporation
        7.3.1 Company Basic Information, Manufacturing Base and Competitors
        7.3.2 Myotonic Dystrophy Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Genzyme Corporation Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.3.4 Main Business/Business Overview
    7.4 Isis Pharmaceuticals, Inc.
        7.4.1 Company Basic Information, Manufacturing Base and Competitors
        7.4.2 Myotonic Dystrophy Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.4.4 Main Business/Business Overview
    7.5 Marina Biotech, Inc.
        7.5.1 Company Basic Information, Manufacturing Base and Competitors
        7.5.2 Myotonic Dystrophy Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Marina Biotech, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.5.4 Main Business/Business Overview
    7.6 Valentia Biopharma S.L.
        7.6.1 Company Basic Information, Manufacturing Base and Competitors
        7.6.2 Myotonic Dystrophy Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.6.4 Main Business/Business Overview

8 Myotonic Dystrophy Drug Manufacturing Cost, Industrial Chain and Downstream Buyers
    8.1 Myotonic Dystrophy Drug Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
    8.3 Myotonic Dystrophy Drug Industrial Chain Analysis
    8.4 Downstream Buyers in United States

9 Marketing Strategy Analysis, Distributors and Market Effect Factors
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Distributors in Untied States
    9.3 Market Effect Factors Analysis
        9.3.1 Economic/Political Environmental Change
        9.3.2 Downstream Demand Change
        9.3.3 Technology Progress in Related Industry
        9.3.4 Substitutes Threat

10 Global Myotonic Dystrophy Drug Market Forecast
    10.1 Global Myotonic Dystrophy Drug Sales, Revenue Forecast (2018-2025)
        10.1.1 Global Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.1.2 Global Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.2 United States Myotonic Dystrophy Drug Market Forecast
        10.2.1 United States Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.2.2 United States Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.3 Global Myotonic Dystrophy Drug Forecast by Regions
        10.3.1 North America Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.2 Europe Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.3 Asia-Pacific Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.4 South America Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.5 Middle East and Africa Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
    10.4 Myotonic Dystrophy Drug Forecast by Type
        10.4.1 Global Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
        10.4.2 United States Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
    10.5 Myotonic Dystrophy Drug Forecast by Application
        10.5.1 Global Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Application (2018-2025)
        10.5.2 United States Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 Research Findings and Conclusion



List of Tables and Figures

    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
    Figure Myotonic Dystrophy Drug Product Picture
    Figure Global Myotonic Dystrophy Drug Revenue (Million USD) Status and Outlook (2013-2025)
    Figure United States Myotonic Dystrophy Drug Revenue (Million USD) Status and Outlook (2013-2025)
    Figure Product Picture of ISIS-DMPKRx
    Table Major Players of ISIS-DMPKRx
    Figure Global ISIS-DMPKRx Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of PRO-135
    Table Major Players of PRO-135
    Figure Global PRO-135 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of SRT-152
    Table Major Players of SRT-152
    Figure Global SRT-152 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of VAL-0411
    Table Major Players of VAL-0411
    Figure Global VAL-0411 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of Others
    Table Major Players of Others
    Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) by Type (2013-2018)
    Table Global Myotonic Dystrophy Drug Sales Share (%) by Type (2013-2018)
    Figure Global Myotonic Dystrophy Drug Sales Market Share (%) by Type (2013-2018)
    Figure Global Myotonic Dystrophy Drug Sales Market Share (%) by Type in 2017
    Table Global Myotonic Dystrophy Drug Revenue (Million USD) by Type (2013-2018)
    Table Global Myotonic Dystrophy Drug Revenue Share (%) by Type (2013-2018)
    Figure Global Myotonic Dystrophy Drug Revenue Share (%) by Type (2013-2018)
    Figure 2017 Global Myotonic Dystrophy Drug Revenue Market Share (%) by Type
    Table Global Myotonic Dystrophy Drug Price (USD/Pcs) by Type (2013-2018)
    Table United States Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table United States Myotonic Dystrophy Drug Sales (K Pcs) by Type (2013-2018)
    Table United States Myotonic Dystrophy Drug Sales Share (%) by Type (2013-2018)
    Figure United States Myotonic Dystrophy Drug Sales Market Share (%) by Type (2013-2018)
    Figure United States Myotonic Dystrophy Drug Sales Market Share (%) by Type in 2017
    Table United States Myotonic Dystrophy Drug Revenue (Million USD) by Type (2013-2018)
    Table United States Myotonic Dystrophy Drug Revenue Share (%) by Type (2013-2018)
    Figure United States Myotonic Dystrophy Drug Revenue Share (%)by Type (2013-2018)
    Figure 2017 United States Myotonic Dystrophy Drug Revenue Market Share (%) by Type
    Table United States Myotonic Dystrophy Drug Price (USD/Pcs) by Type (2013-2018)
    Figure Hospital Examples
    Figure Clinic Examples
    Figure Home Use Examples
    Figure Others Examples
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) Comparison by Application (2013-2025)
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) by Application (2013-2018)
    Table Global Myotonic Dystrophy Drug Sales Share (%) by Application (2013-2018)
    Figure Global Myotonic Dystrophy Drug Sales Market Share (%) by Application (2013-2018)
    Figure Global Myotonic Dystrophy Drug Sales Market Share (%) by Application in 2017
    Table United States Myotonic Dystrophy Drug Sales (K Pcs) Comparison by Application (2013-2025)
    Table United States Myotonic Dystrophy Drug Sales (K Pcs) by Application (2013-2018)
    Table United States Myotonic Dystrophy Drug Sales Share (%) by Application (2013-2018)
    Figure United States Myotonic Dystrophy Drug Sales Market Share (%) by Application (2013-2018)
    Figure United States Myotonic Dystrophy Drug Sales Market Share (%) by Application in 2017
    Table Global Myotonic Dystrophy Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
    Figure North America Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Asia-Pacific Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Europe Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure South America Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Middle East and Africa Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure United States Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) by Regions (2013-2018)
    Table Global Myotonic Dystrophy Drug Sales Market Share (%) by Regions (2013-2018)
    Figure Global Myotonic Dystrophy Drug Sales Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Myotonic Dystrophy Drug Sales Market Share (%) by Regions
    Figure 2017 United States Myotonic Dystrophy Drug Sales Market Share (%) in Global Market
    Table Global Myotonic Dystrophy Drug Revenue (Million USD) by Regions (2013-2018)
    Table Global Myotonic Dystrophy Drug Revenue Market Share (%) by Regions (2013-2018)
    Figure Global Myotonic Dystrophy Drug Revenue Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Myotonic Dystrophy Drug Revenue Market Share (%) by Regions
    Figure 2017 United States Myotonic Dystrophy Drug Revenue Market Share (%) in Global Market
    Table Global Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table North America Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Europe Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Asia-Pacific Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table South America Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Middle East and Africa Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table United States Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) of Key Players (2013-2018)
    Table Global Myotonic Dystrophy Drug Sales Share (%) by Players (2013-2018)
    Figure 2017 Global Myotonic Dystrophy Drug Sales Share (%) by Players
    Figure 2018 Global Myotonic Dystrophy Drug Sales Share (%) by Players
    Table Global Myotonic Dystrophy Drug Revenue (Million USD) by Players (2013-2018)
    Table Global Myotonic Dystrophy Drug Revenue Share (%) by Players (2013-2018)
    Table 2017 Global Myotonic Dystrophy Drug Revenue Share (%) by Players
    Table 2018 Global Myotonic Dystrophy Drug Revenue Share (%) by Players
    Table Global Market Myotonic Dystrophy Drug Average Price (USD/Pcs) by Players (2013-2018)
    Table Global Myotonic Dystrophy Drug Top Players Manufacturing Base Distribution and Sales Area
    Table Global Myotonic Dystrophy Drug Top Players Product Category
    Figure Global Myotonic Dystrophy Drug Market Share (%) of Top 3 Players
    Figure Global Myotonic Dystrophy Drug Market Share (%) of Top 5 Players
    Table United States Myotonic Dystrophy Drug Sales (K Pcs) by Players (2013-2018)
    Table United States Myotonic Dystrophy Drug Sales Market Share (%) by Players (2013-2018)
    Figure 2017 United States Myotonic Dystrophy Drug Sales Share (%) by Players
    Figure 2018 United States Myotonic Dystrophy Drug Sales Share (%) by Players
    Table United States Myotonic Dystrophy Drug Revenue (Million USD) by Players (2013-2018)
    Table United States Myotonic Dystrophy Drug Revenue Market Share (%) by Players (2013-2018)
    Table 2017 United States Myotonic Dystrophy Drug Revenue Share (%) by Players
    Table 2018 United States Myotonic Dystrophy Drug Revenue Share (%) by Players
    Table United States Market Myotonic Dystrophy Drug Average Price (USD/Pcs) by Players (2013-2018)
    Figure United States Myotonic Dystrophy Drug Market Share (%) of Top 3 Players
    Figure United States Myotonic Dystrophy Drug Market Share (%) of Top 5 Players
    Table BioMarin Pharmaceutical Inc. Basic Information List
    Table BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales Growth Rate (2013-2018)
    Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales Global Market Share (%)(2013-2018)
    Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Revenue Global Market Share (%)(2013-2018)
    Table F. Hoffmann-La Roche Ltd. Basic Information List
    Table F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales Growth Rate (2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales Global Market Share (%)(2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Revenue Global Market Share (%)(2013-2018)
    Table Genzyme Corporation Basic Information List
    Table Genzyme Corporation Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Genzyme Corporation Myotonic Dystrophy Drug Sales Growth Rate (2013-2018)
    Figure Genzyme Corporation Myotonic Dystrophy Drug Sales Global Market Share (%)(2013-2018)
    Figure Genzyme Corporation Myotonic Dystrophy Drug Revenue Global Market Share (%)(2013-2018)
    Table Isis Pharmaceuticals, Inc. Basic Information List
    Table Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales Growth Rate (2013-2018)
    Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales Global Market Share (%)(2013-2018)
    Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Revenue Global Market Share (%)(2013-2018)
    Table Marina Biotech, Inc. Basic Information List
    Table Marina Biotech, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Sales Growth Rate (2013-2018)
    Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Sales Global Market Share (%)(2013-2018)
    Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Revenue Global Market Share (%)(2013-2018)
    Table Valentia Biopharma S.L. Basic Information List
    Table Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales Growth Rate (2013-2018)
    Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales Global Market Share (%)(2013-2018)
    Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Revenue Global Market Share (%)(2013-2018)
    Table Sales Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Myotonic Dystrophy Drug
    Figure Myotonic Dystrophy Drug Industrial Chain Analysis
    Table Major Buyers of Myotonic Dystrophy Drug
    Table Distributors/Traders List
    Figure Global Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Global Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Myotonic Dystrophy DrugMyotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Regions (2018-2025)
    Figure Global Myotonic Dystrophy Drug Sales Market Share (%) Forecast by Regions (2018-2025)
    Figure North America Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure North America Myotonic Dystrophy Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Myotonic Dystrophy Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Myotonic Dystrophy Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure South America Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure South America Myotonic Dystrophy Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Myotonic Dystrophy Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Table Global Myotonic Dystrophy Drug Sales (Million USD) Forecast by Type (2018-2025)
    Figure Global Myotonic Dystrophy Drug Sales Market Share (%) Forecast by Type (2018-2025)
    Table Global Myotonic Dystrophy Drug Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Myotonic Dystrophy Drug Revenue Market Share (%) Forecast by Type (2018-2025)
    Table United States Myotonic Dystrophy Drug Sales (Million USD) Forecast by Type (2018-2025)
    Figure United States Myotonic Dystrophy Drug Sales Market Share (%) Forecast by Type (2018-2025)
    Table United States Myotonic Dystrophy Drug Revenue (Million USD) Forecast by Type (2018-2025)
    Figure United States Myotonic Dystrophy Drug Revenue Market Share (%) Forecast by Type (2018-2025)
    Table Global Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Application (2018-2025)
    Figure Global Myotonic Dystrophy Drug Sales Forecast by Application (2018-2025)
    Table United States Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Application (2018-2025)
    Figure United States Myotonic Dystrophy Drug Sales Forecast by Application (2018-2025)

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@e-marketresearch.com